Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;13(3):507-514.
doi: 10.4168/aair.2021.13.3.507.

Specialist Perception of Severe Asthma in Korea: A Questionnaire Survey

Affiliations

Specialist Perception of Severe Asthma in Korea: A Questionnaire Survey

Mi Ae Kim et al. Allergy Asthma Immunol Res. 2021 May.

Abstract

The Working Group on Severe Asthma of the Korean Academy of Allergy and Clinical Immunology recently published an expert opinion paper on the management of severe asthma in Korea. When developing a consensus, the working group encountered several diagnostic and treatment issues and decided to perform a questionnaire survey of Korean specialists with regard to severe asthma. An e-mail with a uniform resource locator link to the questionnaire was sent to 121 asthma specialists, of whom 44.6% responded. The most commonly accepted definitions of severe asthma were a history of fatal exacerbation or an asthma-triggered need for mechanical ventilation, 3-4 oral corticosteroid (OCS) bursts/year, and maintenance of OCS therapy for 3-6 months per year. Before diagnosing severe asthma, most physicians contemplate chest computed tomography, seek to control chronic rhinosinusitis, and consider poor inhaler compliance. For patients with uncontrolled severe asthma accompanied by type 2 (T2)-high inflammation, most biologics available in Korea were considered appropriate, but gaps were apparent in terms of T2-low asthma treatments. These findings about specialist perception of diagnosis and treatment of severe asthma will inform the use of emerging new drugs and facilitate personalized therapy.

Keywords: Asthma; biological products; consensus; diagnosis; disease management; standards; surveys and questionnaires; therapeutics.

PubMed Disclaimer

Conflict of interest statement

There are no financial or other issues that might lead to a conflict of interest.

Figures

Fig. 1
Fig. 1. Proportions of agreement (mean scores of over 3) in terms of defining ACO in patients with severe asthma.
ACO, asthma-Chronic Obstructive Respiratory Disease overlap; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; CT, computed tomography.
Fig. 2
Fig. 2. A graphical summary of specialists' perceptions of severe asthma.
ER, emergency room; OCS, oral corticosteroid; FEV1, forced expiratory volume in 1 second; CT, computed tomography; IgE, immunoglobulin E; ANCA, anti-neutrophil cytoplasmic antibodies; CRS, chronic rhinosinusitis; ICS, inhaled corticosteroid; LABA, long-acting beta-2 agonist; IL5, interleukin 5; IL5R, interleukin 5 receptor; IL4R, interleukin 4 receptor; PDE4, phosphodiesterase 4; TSLP, thymic stromal lymphopoietin.

References

    1. Kang SY, Song WJ, Cho SH, Chang YS. Time trends of the prevalence of allergic diseases in Korea: a systematic literature review. Asia Pac Allergy. 2018;8:e8. - PMC - PubMed
    1. Chen S, Golam S, Myers J, Bly C, Smolen H, Xu X. Systematic literature review of the clinical, humanistic, and economic burden associated with asthma uncontrolled by GINA Steps 4 or 5 treatment. Curr Med Res Opin. 2018;34:2075–2088. - PubMed
    1. Ivanova JI, Bergman R, Birnbaum HG, Colice GL, Silverman RA, McLaurin K. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma. J Allergy Clin Immunol. 2012;129:1229–1235. - PubMed
    1. Kim S, Kim J, Kim K, Kim Y, Park Y, Baek S, et al. Healthcare use and prescription patterns associated with adult asthma in Korea: analysis of the NHI claims database. Allergy. 2013;68:1435–1442. - PubMed
    1. Global Initiative for Asthma. Global strategy for asthma management and prevention, 2020. Fontana: GINA; 2020. [cited 2020 Sep 15]. Available from: www.ginasthma.org.